Michael Dombeck | Vice President Of Business Development
Precision Biocciences

Michael Dombeck, Vice President Of Business Development, Precision Biocciences

Mike Dombeck leads business development at Precision BioSciences. Prior to joining Precision, Mike was a Director in GlaxoSmithKline’s R&D Strategy and Portfolio Management group. Mike has nearly 20 years of industry experience, spanning market research and portfolio planning with Talecris, business development for DarPharma, Inc., business development and corporate strategy consulting with Campbell Alliance, and as a co-founder of Cempra Pharmaceuticals. When he’s not deal-making, Mike enjoys coaching his daughters’ soccer teams, learning slow-cooking techniques, and exploring the world through a camera lens. Mike completed both his undergraduate and graduate studies at Duke University, with an MBA and Master of Public Policy, and a B.S. in biology and health policy.


Conference Day 1: Thursday 16th May 2019 @ 16:25

Short (10 minute) company presentations followed by panel discussion: Development strategies for CAR-T and TCR therapies with the late stage in mind

  • Allogenic vs autologous
  • Understanding different opportunities: selecting the correct product for the appropriate purpose
  • Improving outcomes tackling solid tumourswith CAR-T therapy
  • Moving towards a more off the shelf approach for better cost of goods
last published: 21/Mar/19 09:25 GMT

back to speakers

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.


Erica Baeta 
+44 (0)207 092 1152 


Jessica Robinson 
t/ +44 (0)207 092 1150 


Issa Mauthoor 
+44 (0)207 092 1257